» Articles » PMID: 17259475

Effects of Treatment Targets on Subsequent Cardiovascular Events in Chinese Patients with Type 2 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2007 Jan 30
PMID 17259475
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: International guidelines recommend optimal control of risk factors in diabetes to prevent cardiovascular events. We examined risk associations between achieving treatment targets for glycemia, blood pressure and lipid control, and other risk factors on subsequent cardiovascular events in Chinese patients with type 2 diabetes.

Research Design And Methods: Between 1995 and 2005, 6,386 Chinese type 2 diabetic patients without a history of coronary heart disease (CHD) or stroke were recruited. They were classified according to the number of treatment targets attained at baseline, and their cardiovascular outcomes were compared. Treatment targets were defined as A1C <7.0%, blood pressure <130/80 mmHg, and LDL cholesterol <2.6 mmol/l.

Results: After a median follow-up of 5.7 years, cumulative incidence of CHD or stroke (n = 749) increased with decreasing numbers of treatment targets attained at baseline. Attainment of two or more targets at baseline was associated with reduced risk of CHD compared with those with no target achieved (hazard ratio 0.69 [95% CI 0.50-0.94], P = 0.020). However, the association lost its significance after adjustment for urinary albumin-to-creatinine ratio, estimated glomerular filtration rate, and hemoglobin.

Conclusions: Reaching more treatment targets was associated with reduced risk of new onset of CHD in Chinese patients with type 2 diabetes.

Citing Articles

Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries.

Cheung J, Lau E, Tsui C, Siu E, Tse N, Hui N BMC Med. 2022; 20(1):249.

PMID: 35831899 PMC: 9281062. DOI: 10.1186/s12916-022-02424-y.


Plasma Free Amino Acids and Risk of Cardiovascular Disease in Chinese Patients With Type 2 Diabetes.

Li T, Luo H, Feng X, Bai Y, Fang Z, Wu G Front Endocrinol (Lausanne). 2021; 11:519923.

PMID: 33935960 PMC: 8081348. DOI: 10.3389/fendo.2020.519923.


Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.

Lim L, Lau E, Fu A, Ray S, Hung Y, Tan A JAMA Netw Open. 2021; 4(4):e217557.

PMID: 33929522 PMC: 8087959. DOI: 10.1001/jamanetworkopen.2021.7557.


Associations of ABC (Hemoglobin A1c, Blood Pressure and Low-Density Lipoprotein Cholesterol) Goal Achievement With Chronic Kidney Disease in Type 2 Diabetic Patients With Preserved Kidney Function.

Minato S, Takenouchi A, Kitaoka K, Takeuchi M, Tsuboi A, Kurata M J Clin Med Res. 2019; 11(12):818-824.

PMID: 31803326 PMC: 6879039. DOI: 10.14740/jocmr4001.


Depressive Symptoms, Co-Morbidities, and Glycemic Control in Hong Kong Chinese Elderly Patients With Type 2 Diabetes Mellitus.

Fung A, Tse G, Cheng H, Lau E, Luk A, Ozaki R Front Endocrinol (Lausanne). 2018; 9:261.

PMID: 29896155 PMC: 5986894. DOI: 10.3389/fendo.2018.00261.